BSX

Scivita Medical enters into Strategic Agreement with Boston Scientific in China

Retrieved on: 
Wednesday, March 29, 2023
Medicine, Partnership, Marketing, Boston Scientific, BSX, COVID-19, Fujifilm, Endoscopy, Hospital, Urology, Patient, Risk, Gynaecology, NYSE, Pharmaceutical industry, Medical device, EU

SUZHOU, China, March 29, 2023 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ('Scivita Medical') and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed a Strategic Agreement for Scivita's Single-Use Percutaneous Choledochoscope.

Key Points: 
  • SUZHOU, China, March 29, 2023 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ('Scivita Medical') and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed a Strategic Agreement for Scivita's Single-Use Percutaneous Choledochoscope.
  • Through this business cooperation and distribution agreement, Scivita Medical and Boston Scientific plan to establish a long-term partnership in the commercialization, marketing and promotion of Scivita's Single-Use Percutaneous Choledochoscope in China.
  • Through the strong alliance with Boston Scientific, the penetration rate of the Single-Use Percutaneous Choledochoscope in China is expected to increase benefiting more hospitals and patients.
  • Scivita Medical said, 'Thanks to Boston Scientific for its recognition of Scivita Medical.

EQS-News: More patient safety with simulators for cardiologists – SHS invests 10 million euro in Swiss Simulands AG

Retrieved on: 
Thursday, March 2, 2023
NYSE, Safety, Aircraft, Research, Abbott Laboratories, Aviation, Patient, Boston Scientific, Animal, Cardiology, Learning, Medicine, SHS, Environment, Medtech, Growth, BSX, Physician, Nursing

SHS invests in Simulands AG, a Swiss manufacturer of simulation equipment for medical training of cardiac interventions.

Key Points: 
  • SHS invests in Simulands AG, a Swiss manufacturer of simulation equipment for medical training of cardiac interventions.
  • Based on the same concept, Simulands builds tools that enable cardiologists and echocardiographers to train in performing complex cardiovascular interventional procedures risk-free using human-grade simulators.
  • "With the investment into Simulands AG, we are pleased to make our first investment from our newly launched sixth fund generation.
  • "Partnering with SHS is an invaluable opportunity for Simulands to accelerate its entry to key global markets expanding support to its customers base.

MIAX Wins Multiple Industry Awards for Trading Technology and Innovation

Retrieved on: 
Friday, February 24, 2023
Emerald, NOVA, Bermuda Stock Exchange, Futures Industry Association, Senior, Service, Organization, Research, United Nations Public Service Awards, BSX, Minneapolis Grain Exchange, Financial adviser, Cryptocurrency

PRINCETON, N.J., Feb. 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc., owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, announced today that MIAX has been named the "Best Trading Platform" at the Fund Intelligence Operations and Services Awards 2023 .

Key Points: 
  • PRINCETON, N.J., Feb. 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc., owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, announced today that MIAX has been named the "Best Trading Platform" at the Fund Intelligence Operations and Services Awards 2023 .
  • MIAX was also selected as one of 40 organizations in the inaugural TabbFORUM's NOVA Awards, which honor the financial industry's ongoing commitment to technology-driven innovation.
  • "The MIAX technology team is dedicated to building high performance trading systems designed to withstand the high throughput demands of today's derivatives markets," said Matt Rotella, Senior Vice President and Chief Technology Officer of MIAX.
  • MIAX won the "Most Innovative Technology" category from 2017 to 2020 and received the "Best Options Trading Platform" award in 2021.

MIAX Wins Multiple Industry Awards for Trading Technology and Innovation

Retrieved on: 
Friday, February 24, 2023
Emerald, NOVA, Bermuda Stock Exchange, Futures Industry Association, Senior, Service, Organization, Research, United Nations Public Service Awards, BSX, Minneapolis Grain Exchange, Financial adviser, Cryptocurrency

PRINCETON, N.J., Feb. 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc., owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, announced today that MIAX has been named the "Best Trading Platform" at the Fund Intelligence Operations and Services Awards 2023 .

Key Points: 
  • PRINCETON, N.J., Feb. 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc., owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, announced today that MIAX has been named the "Best Trading Platform" at the Fund Intelligence Operations and Services Awards 2023 .
  • MIAX was also selected as one of 40 organizations in the inaugural TabbFORUM's NOVA Awards, which honor the financial industry's ongoing commitment to technology-driven innovation.
  • "The MIAX technology team is dedicated to building high performance trading systems designed to withstand the high throughput demands of today's derivatives markets," said Matt Rotella, Senior Vice President and Chief Technology Officer of MIAX.
  • MIAX won the "Most Innovative Technology" category from 2017 to 2020 and received the "Best Options Trading Platform" award in 2021.

Blackstone Minerals Announces Participation in Red Cloud's 2023 Pre-PDAC Mining Showcase

Retrieved on: 
Thursday, February 16, 2023
Cloud, Red Cloud, ASX, BSX, Sheraton Centre Toronto Hotel, Mitchell Red Cloud Jr., Eastern Standard, BD, Rare-earth element

Perth, Western Australia, Australia--(Newsfile Corp. - February 16, 2023) - Blackstone Minerals (ASX: BSX) is pleased to announce that the Company will be presenting at Red Cloud's Pre-PDAC 2023 Mining Showcase.

Key Points: 
  • Perth, Western Australia, Australia--(Newsfile Corp. - February 16, 2023) - Blackstone Minerals (ASX: BSX) is pleased to announce that the Company will be presenting at Red Cloud's Pre-PDAC 2023 Mining Showcase.
  • We invite our shareholders and all interested parties to join us.
  • The annual conference will take place in-person at the Sheraton Centre Toronto Hotel from March 2-3, 2023.
  • Andrew Strickland, Executive, BD will be presenting on March 2nd at 3:30PM Eastern Standard time.

BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX

Retrieved on: 
Saturday, February 18, 2023
Class Action Lawsuit, Professional Services, Legal, LOTUS, Boston Scientific, NYSE, KSF, BSX, Private investigator

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Boston Scientific Corporation (NYSE: BSX).

Key Points: 
  • Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Boston Scientific Corporation (NYSE: BSX).
  • Recently, the court presiding over that case denied the Company’s motion to dismiss in part, allowing the case to move forward.
  • KSF’s investigation is focusing on whether Boston Scientific’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms.

BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX

Retrieved on: 
Monday, January 23, 2023
Class Action Lawsuit, Professional Services, Legal, LOTUS, Boston Scientific, NYSE, KSF, BSX, Private investigator

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Boston Scientific Corporation (NYSE: BSX).

Key Points: 
  • Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Boston Scientific Corporation (NYSE: BSX).
  • Recently, the court presiding over that case denied the Company’s motion to dismiss in part, allowing the case to move forward.
  • KSF’s investigation is focusing on whether Boston Scientific’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms.

Boston Scientific to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference

Retrieved on: 
Monday, February 13, 2023
BSX, Boston Scientific, EST, NYSE, Conference, Medtech, Webcast, Citigroup

MARLBOROUGH, Mass., Feb. 13, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Wednesday, March 1, 2023.

Key Points: 
  • MARLBOROUGH, Mass., Feb. 13, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Wednesday, March 1, 2023.
  • Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 40-minute question-and-answer session with the host analyst at approximately 8:00 a.m. EST.
  • A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com .
  • The replay of the webcast will be accessible at investors.bostonscientific.com .

Boston Scientific Receives FDA Clearance for LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System

Retrieved on: 
Friday, February 3, 2023
Health, Kidney, SIRS, Kidney stone disease, Food and Drug Administration, NYSE, Sepsis, Ureteroscopy, Pressure, University, Urology, Food, Technical University of British Columbia, IRP, FDA, BSX, Infection, Research, System, Systemic inflammatory response syndrome, Medical device, Medical imaging, Video game, Boston Scientific

MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.

Key Points: 
  • MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.
  • The LithoVue Elite System, comprised of the single-use digital flexible ureteroscope and the StoneSmart™ Connect Console, builds on many of the features of the original LithoVue™ System with significant next-generation innovations.
  • The LithoVue Elite System is the latest device in the Boston Scientific single-use imaging portfolio, developed with physician feedback to advance patient care and eliminate infection risk associated with ineffective reprocessing of reusable scopes.
  • For more information about kidney stone solutions from Boston Scientific, please visit www.bostonscientific.com/LithoVueElite or StoneSmart.com .

AM Best Affirms Credit Ratings of Argus Group Holdings Limited and Its Subsidiaries

Retrieved on: 
Friday, January 13, 2023
Insurance, Professional Services, AM Best, News, BSX, Credit, COVID-19, FSR, International, ALL, Policy, Growth, Argus, Risk management, AM, Acquisition, Good, Investment

Both companies are subsidiaries of Argus Group Holdings Limited (Argus Group) [BSX: AGH.BH].

Key Points: 
  • Both companies are subsidiaries of Argus Group Holdings Limited (Argus Group) [BSX: AGH.BH].
  • Concurrently, AM Best has affirmed the Long-Term ICR of “bbb-” (Good) of Argus Group.
  • The ratings reflect Argus Group’s balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .